BACKGROUND: Couples with recurrent miscarriages make several visits to specialized clinics for investigations before treatment is offered. Consequently, 'the interval' between receipt of referral and advice to try for a pregnancy is often lengthy. The objectives of this study were to examine the effect of a 'one-stop' clinic on 'the interval', throughput and the outcome from this clinic. METHODS: The processes for investigation, management and outcomes of 189 couples seen in our Recurrent Miscarriage Clinic (RMC) and their records were reviewed. RESULTS: The one-stop clinic reduced the interval and number of visits by 36% (206.6 to 130.4 days, P < 0.001) and by 60% (2.5 to 1, P < 0.002) respectively. The prevalence and frequency of aetiological factors were similar in those with two and three or more miscarriages (41% versus 45%, P > 0.05). The commonest aetiological factors were thrombophilias (14%) and antiphospholipid syndrome (11%). No cause was identified in 54% of cases. The pregnancy and live birth rates were best in the idiopathic group (75%), those with thrombophilias (64%) and autoimmune antibodies (83%). Older couples had the worse pregnancy rates and outcome. CONCLUSION: A one-stop clinic significantly shortens 'the interval' between referral and initiation of treatment. Investigations should be initiated in women after two consecutive miscarriages.
Introduction
Recurrent miscarriages (RM) affect between 0.5 and 3% of couples (Li et al., 2002a) . Although most gynaecologists see and investigate these couples, it is becoming increasingly recognized that the best care is offered in a dedicated clinic governed by evidence-based guidelines. Outcomes from such clinics are significantly better not only because of the more extensive investigations and tailored treatment, but the supportive care the dedicated staff offer.
East Midlands is a large region in England with a population of , 1.5 £ 10 6 . A dedicated Recurrent Miscarriage Clinic (RMC) was started at the Leicester Royal Infirmary in 1999 to cater for couples with this complication. The clinic is run by a team consisting of a consultant, a primary nurse, a nurse counsellor, a clinic coordinator and a clinical research fellow. Only women who have had at least two consecutive miscarriages are eligible to be seen in the clinic.
The patients seen in the clinic are referred by their own General Practitioners (GPs), other gynaecologists or the Early Pregnancy Assessment Clinic (EPAC). For the first 12 months of the clinic, a number of investigations was undertaken at the initial visit and then reviewed at follow-up appointments often 3-5 months later. The plan of management for any ensuing pregnancy was discussed at these follow-up visit in the light of the results of the investigations.
This often meant a delay of , 6 -9 months between receiving the initial referral and deciding on the management plan because of capacity and demand.
As the number of referrals to the clinic increased, its capacity was overstretched, and even further by the followup appointments. By the end of the first 12 months the average waiting time before the first visit to the clinic had risen from 2-3 to 9 -12 months. This was unacceptable to most couples who had suffered significant distress during the waiting. A review of the processes within the clinic was therefore undertaken and the result was the establishment of the onestop RMC. In this paper we present the processes within this one-stop clinic since its inception and the results of investigations, treatment and outcome over a 4 year period. Figure 1 shows the processes within the one-stop clinic. Briefly, on receiving a referral letter, the clinic coordinator sends a standard letter to the couple. This letter contains details of the processes in the clinic and an instruction not to become pregnant until after a visit to the clinic. Failure to adhere to this policy results in cancellation of the appointment. Forms for the investigations (Table I) and detailed instructions on where and when to attend the hospital for the blood samples to be taken (usually during the follicular phase of the menstrual cycle, i.e. first 2 -3 days) are enclosed with the letter.
Materials and methods
The results of these investigations are then collated by the clinic co-ordinator and the consultant's secretary. These are reviewed by the consultant and documented in the patient's notes. An appointment for the clinic is then sent to the patient once the complete set of results is available, usually within 2 -3 weeks. At the clinic, a detailed history and physical examination are undertaken and documented on a proforma. A comprehensive assessment of the couple is made based on the history and physical examination findings and investigations and the plan for care in the next pregnancy is discussed and also documented in the patient's notes. Each couple is then seen by the Nurse Counsellor before leaving the clinic. They are given a direct phone number to the Antenatal Assessment Area (AAA) where all pregnancies are followed up by the consultant. A detailed letter about the consultation is dictated to the patient's GP and copied to the patient and the AAA. When the patient contacts the AAA after a positive pregnancy test, an appointment is made for an ultrasound scan to confirm an intrauterine pregnancy, usually within 1 -2 weeks of the phone call, and thereafter serially as indicated. For most women this is weekly until 12 weeks and thereafter every 2 -4 weeks, depending on the patient's history and perceived level of anxiety. For those requiring treatment such as Dalteparin (Fragmin), this is instituted at the first visit. Once the pregnancy is $12 weeks, the women are encouraged to book with their midwives and GPs. Those requiring supportive care from specialized clinics such as the Obstetric Haematology, Maternal Medicine, Diabetic and Endocrine and Fetal Growth Clinics are then referred to these after 12 weeks.
An embryonic miscarriage was defined as one where the loss was after an ultrasound scan that demonstrated a gestational sac but not a fetal pole, whereas a fetal miscarriage was one following an ultrasound scan which demonstrated a fetal pole and fetal heart activity. Products from the miscarriages, which occurred subsequent to the clinic visit, were sent for karyotyping wherever possible. The results are presented as means and 1 SD where appropriate. Comparisons are made with x 2 -test with significance set at P , 0.05. The review of the outcome from the clinic was considered as an audit and was approved by the unit.
Results
In total, 189 women were seen in the RMC between June 1999 and May 2003. Table II shows some of the characteristics of these women. The mean^SD age was 31.7^6.0 years (range: 19 -44 years). A total of 121 (64%) had no live births before referral; 75 (40%) had two consecutive miscarriages, 81 (43%) had three consecutive miscarriages and 33 (17%) had four or more consecutive miscarriages.
Before the start of the 'one-stop' clinic, the mean^SD time between receiving the referral and the making of a management plan for subsequent pregnancies (referred to as 'the interval') was 206.6^92.2 days (6.9 months) and the mean^SD number of visits to the clinic was 2.5^0.61 (range 1 -4) visits. After establishing the 'one-stop' clinic, 'the interval' fell significantly to 130.4^48.9 (mean^SD) days (4.3 months) (P , 0.001). These reductions were achieved without altering the number of clinics per month. The mean^SD number of new patients seen per clinic increased from 2.75^0.71 to 4.9^1.2; P , 0.005.
Of the 189 women, 103 (54%) had no obvious abnormality detected from the investigations, i.e. they had unexplained recurrent miscarriages. Table III shows the identifiable putative causes of the recurrent miscarriages. The most common were thrombophilias (14%) and antiphospholipid syndrome (11%) and the least common was intrauterine adhesions or Ashermann's syndrome (totalling 0.5%). Some of the abnormal results were of uncertain significance. These included a high HbA1c associated with a normal glucose tolerance test, autoimmune (antismooth muscle, antimitochondrial and antiparietal) antibodies and raised thyroid peroxidase antibodies.
Putative causes for the miscarriages were identified in 31 of the 75 (41%) couples who presented after 2 miscarriages, 37 out of 81 (45%) presenting with three miscarriages and 18 out of 33 (55%) presenting with four or more miscarriages. There was no statistically significant difference (P ¼ 0.2) in the frequency of the identifiable causes in the three groups.
Of the 189 women seen in the clinic, 123 (65%) conceived; 25 of these conceived twice, four conceived three times and one conceived four times. There was therefore a total of 159 pregnancies; 107 (67%) resulted in live births, 36 (23%) in first trimester miscarriages (14 embryonic and 22 fetal), four (2.5%) in second trimester miscarriages, two (1.3%) had ectopic pregnancies and six (3.7%) are ongoing. There were three (1.9%) terminations for fetal anomalies (triploidy, Edward's syndrome and cystic hygroma). One woman relocated to another country at 26 weeks gestation. Although the products of conception from the miscarriages were sent for karyotyping, this was successful in only 13.9% of cases, none of which was abnormal. Table IV shows the relationship between the age at presentation and spontaneous pregnancy rate. The older the woman, the lower the chances of spontaneous pregnancy and the higher the risk of another miscarriage. The best pregnancy and live birth rates were in women aged , 35 years. Although the pregnancy rate in the 36-40 year age group was significantly lower than that for those , 35 years, the live birth rate was similar to that of all the other younger age groups. The relationship between the number of miscarriages, pregnancy and live birth rates is shown in Table V . Although the pregnancy rates were not affected by previous miscarriages, the live birth rate was lowest in those with $ 4 miscarriages. The 20 cases of antiphospholipid syndrome were diagnosed on the basis of raised anticardiolipin antibody (13 women), elevated lupus anticoagulant (six women) or both (one woman) confirmed from two tests 3 months apart. Twelve (60%) of these women had three or more consecutive miscarriages while eight (40%) had two consecutive miscarriages before referral. There were 19 pregnancies; 10 were live births (53%), three are ongoing pregnancies at 34 weeks gestation), four (21%) were first trimester miscarriages (two embryonic and two fetal), one woman had a termination of pregnancy for triploidy and one relocated to another country at 28 weeks gestation. All were treated throughout pregnancy by a combination of low molecular weight heparin and aspirin from the time pregnancy was confirmed.
Fourteen (7%) women had activated protein C resistance (APCR) but subsequent genetic testing revealed Factor V Leiden mutation in only eight (4.2%) cases, all of which were heterozygous. There were 11 (5.8%) cases of protein S deficiency, four (2.1%) with protein C deficiency, two (1.1%) with combined protein C and S deficiencies and one with antithrombin III deficiency. None of the 26 women with thrombophilia had either a personal or family history of deep vein thrombosis or pulmonary embolism. The diagnosis of an abnormal result was based on two tests performed 3 months apart. Sixteen (61%) of the 26 women presented with three or more consecutive miscarriages and 10 (39%) with two consecutive miscarriages. Eight women in this group conceived once, four conceived twice and two conceived three times. Of the resulting 22 pregnancies, 14 (64%) were live births, three first trimester miscarriages (all fetal losses at 10 weeks), one second trimester miscarriage and one termination of pregnancy for Edward's syndrome. Three pregnancies are ongoing; currently 20, 25 and 39 weeks gestation. All these women received low molecular weight heparin during pregnancy.
Karyotyping for both partners was performed on all couples attending the clinic. Abnormalities were detected in nine (4.8%) cases; inversion on chromosome 9 [Inv (9) p1q21] was identified in four paternal and three maternal karyotypes. Other abnormalities included a maternal chromosomal translocation [46 XX t (5,9) (p13, q21)] and a paternal trisomy 21 mosaic (1% T21 of cells). Four (44.4%) of the nine couples in this group presented after two consecutive miscarriages and five (55.6%) after three or more. Five women conceived once and one conceived twice. Of the seven pregnancies, four were live births, one an embryonic first trimester miscarriage, another a miscarriage in the second trimester and one pregnancy was lost to follow-up at 16 weeks as the couple relocated to another country.
Two women had a positive thyroid peroxidase antibody: one had an elevated thyroid-stimulating hormone (TSH) and a normal free thyroxine (Free T4) whereas the other had a high TSH and a free thyroxine (Free T4) at the upper range of normal. Six women were found to have low TSH but normal free thyroxine (Free T4). Two of these subsequently developed hypothyroidism. Another three cases of hypothyroidism were diagnosed for the first time as a part of the investigations performed in the clinic and three were known to be hypothyroid before referral. Out of a total of eight women with hypothyroidism, six conceived resulting in three live births, two first trimester miscarriages (one fetal and one embryonic) and one second trimester miscarriage. All of these pregnancies were managed with thyroxine. Both women with antiperoxidase antibodies conceived and both had live births. No treatment was offered to these women.
Of the seven (3.7%) women with autoantibodies, three had anti-smooth muscle antibodies and two had antimitochondrial antibodies. Liver function tests were normal in these women. Additionally there was one case with a positive antiparietal antibody test and one with elevated rheumatoid factor. Six of these women conceived resulting in five live births and one early miscarriage (embryonic loss). They were treated empirically with low dose (75 mg/day) aspirin.
Hysteroscopy was performed on two women with hypomenorrhoea and previous evacuation of the uterus; the first revealed Ashermann's syndrome which was treated by hysteroscopic adhesiolysis, followed by an intrauterine device and estrogen stimulation; the second revealed a uterine septum which was removed hysteroscopically. Neither of these women has conceived.
Polycystic ovary syndrome (PCOS) was diagnosed in four women by a combination of symptoms: elevated LH:FSH ratio (. 3:1) in the early follicular phase, low sex hormonebinding globulin and a low free androgen index. There were four pregnancies in this group (one conceiving twice) resulting in two live births, one second trimester miscarriage One-stop recurrent miscarriage clinic at 23 weeks gestation following pre-labour preterm rupture of fetal membranes and one first trimester fetal loss. These women received 5000 IU of b-hCG injections weekly up to 12 weeks gestation. Hyperhomocysteinaemia was identified in nine (4.8%) women, five with three or more consecutive miscarriages before referral and four with two. Four of these women conceived once, two conceived twice, one conceived three times and another conceived four times. There was a total of eight (53%) live births, one ongoing pregnancy (29 weeks) and six first trimester miscarriages. Four of the miscarriages were fetal at 11 weeks while the remaining two were embryonic early miscarriages at 5 weeks gestation. All of these women were treated with a combination of folic acid (5 mg/day), vitamin B 12 (100 mg/day) and vitamin C (50 mg/day), commenced before pregnancy and continued throughout gestation.
The five women with high HbA1c but normal glucose tolerance test were grouped as idiopathic with those in whom no factor was identified. Of the 103 (54%) women in this group, there was a total of 75 pregnancies; 50 women conceived once, 11 conceived twice and one conceived three times; 56 (75%) were live births, 15 (20%) first trimester miscarriages with eight embryonic losses and seven fetal losses, one termination for multiple structural abnormalities and three (4%) ongoing (. 24 weeks gestation).
Discussion
The establishment of the one-stop clinic not only reduced the number of visits to the clinic by 60% but the interval between referral and the making of a management plan for the next pregnancy also fell from 29.5 weeks to 18.6 weeks. Such a reduction was not only beneficial to the individual patients but also enabled more patients to be seen within a shorter time-frame. Despite these advantages, the long wait (sometimes up to 2 months) between blood sampling and the clinic visit caused considerable anxiety to some of the couples. The interval between referral and the first consultation would have been shortened considerably but for the need to have the blood investigations during menstruation (those patients who had to wait longer for a period therefore had an increased interval). In addition, for those patients referred soon after a miscarriage, the mandatory wait of 3 months to ensure that the physiological changes associated with pregnancy had been reversed meant a further prolongation of this interval.
Although the definition of recurrent miscarriages has traditionally been three or more consecutive miscarriages (Li et al., 2002a) , there is an increasing acceptance that couples should be investigated after two miscarriages (Quenby and Farquharson, 1993; Stephenson et al., 1998) . The traditional approach is based on the assumption that the prevalence of possible causes will be significantly different in those with two compared to those with three or more miscarriages. We did not find such a difference. There is therefore no justification in denying couples investigations after two consecutive miscarriages. Whether the gestational age at which the miscarriages occur influences the prevalence of the aetiological factors remains to be seen.
A prevalence of 29.8% for the prothrombotic state was similar to the 25% reported by Li et al. (2002b) . However, chromosomal (4.8%), structural uterine anomaly (1%) and endocrine (7.9%) abnormalities were less common than reported by Li et al. (2002b) . The lower prevalence of uterine anomalies in our series could, however, be explained by the differences in the investigations for these anomalies. We did not routinely offer all our patients timed endometrial biopsies and pelvic ultrasound scans. This would have enabled us to identify not only those women with uterine myomata and other congenital malformations but those with luteal phase defects. Consequently our unexplained category of 54% was higher than that of Li et al. (2002b) , but was within the prevalence of 11 -55% reported in the literature (StrayPedersen and Stray-Pedersen, 1984; Coulam et al., 1995) . Hyperhomocysteinaemia reported by Nelen et al. (2000) as a cause of recurrent miscarriages was present in 4.8% of our patients. The role of investigating for thyroid dysfunction in asymptomatic women with recurrent miscarriages, however, remains uncertain. Drakeley et al. (1998) identified 2% of their cases with thyroid dysfunction, while we identified 4.2%. The most difficult cases were those with raised TSH and normal free thyroxine (Free T4) and those with raised thyroid peroxidase antibodies. Although these were not treated, we have been advised by the endocrinologist that these women are at a significantly increased risk of hypothyroidism and should be monitored by yearly thyroid function test (personal communications). In fact, two of our patients with raised TSH and normal free thyroxine (Free T4) (compensatory euthyroid) became overtly hypothyroid.
The live birth rate of 67% in our series is similar to that reported by others (Li et al., 2002b; Morikawa et al., 2003) . The rate was similar in women aged , 40 years although the pregnancy rates were much higher in those aged , 35 years compared to those aged 35 -40 years. Those aged . 40 years were not only less likely to conceive spontaneously but were significantly more likely to miscarry. Women with two or three miscarriages had a similar live birth rate (67 versus 73%, P . 0.05) whereas those with four or more miscarriages had a lower live birth rate 50%).
The idiopathic group (75%) had the highest live birth rate, similar to rates quoted in the literature (Liddell et al., 1991; Clifford et al., 1997) . Although the rate was highest in those with autoimmune antibodies (85%) the numbers in the group were small. The live birth rate was lowest in those with abnormal karyotypes (57%), hyperhomocysteinaemia (53%) and hypothyroidism (50%). The pregnancy loss rates in the couples with abnormal karyotypes is expected to be higher especially if the fetus is karyotypically abnormal; however, for the other two groups, we have been able to review our approach to their management. For example, while we were not stressing the importance of normal homocysteine levels before pregnancy after initiating treatment for the hyperhomocysteinaemias, we now make every effort to ensure that this is indeed the case. This approach appears to have improved the chances of a live birth in this group.
Those with thyroid dysfunction were unfortunately not treated until much later, as they had presented with compensatory euthyroidism. Whether they should be offered thyroxine empirically or not remains to be resolved. There have been some suggestions by endocrinologists that these should be treated with an empirical dose of thyroxine (50 -100 mg/day) but this is yet to be adopted in our clinic. The same applies to those with raised thyroid peroxidase antibodies. We are collecting these cases and will hopefully review them when the numbers are large enough to make any meaningful conclusions.
The outcome for those with antiphospholipid syndrome (53%) was much poorer than that for other groups (70 -77%) (Kutteh, 1996; Granger and Farquharson, 1997; Rai et al., 1997; Li et al., 2002b) . However, if we include the one patient who relocated and the three with ongoing pregnancies beyond 24 weeks gestation, this value will rise to 73%, which is in keeping with the value of 70 -77%. We treated these patients with a combination of both aspirin and Dalteparin (Fragmin) throughout pregnancy. Although Rai et al. (1997) recommended stopping the anticoagulant therapy at 34 weeks, others have suggested continuing with treatment throughout pregnancy (Farquharson et al., 2002; Li et al., 2002a) , the rationale for this being that the risk of thrombosis does not diminish with gestation and therefore the thromboprophylactic value should remain. However, the findings from randomized controlled trials that the outcome of pregnancies in 'placebo'-and 'aspirin'-treated groups (Pattison et al., 2000) and 'aspirin'-and 'aspirin and heparin'-treated groups Farquharson et al., 2002) were similar questions the rationale for intervention in these women. Since the numbers in these studies are small, the consensus is to continue the present approach. There is emerging evidence that antiphospholipid syndrome may in fact cause recurrent pregnancy losses by interfering with trophoblast development and differentiation (Chamley et al., 1998) . If this is indeed the case, then there may well be a strong reason for starting treatment earlier, but there is as yet no evidence to support this approach.
Although inheritable thrombophilias as a cause of recurrent miscarriage is controversial, with some studies suggesting an increased risk (Grandone et al., 1997; Younis et al., 2000; Vossen et al., 2004 ) and other studies not (Rai et al., 2001) , we found a prevalence of 14% in our population. The most common, that for factor V Leiden, had a prevalence of 4.2%, which is similar to the 3 -4% for the general UK population (Li et al., 2002a) . Perhaps in such a highly selected group, this would have been expected to be higher. For the other thrombophilias, while the population prevalence is low (Li et al., 2002a) we had a higher prevalence of 5.8% for protein S deficiency, 2.1% for protein C deficiency, 1.1% for combined protein C and S deficiencies and 0.5% for antithrombin III deficiency. All these women were treated with Dalteparin (Fragmin) as recommended by Brenner et al. (2000) and the live birth rate in the group was 64% which is in keeping with that of Brenner et al. (2000) but significantly higher than the 20% in an untreated group . Li et al. (2002a) on the other hand suggest that routine treatment with low molecular weight heparin or heparin in this group is not indicated. In the absence of randomized controlled trials, we feel this will remain contentious.
We offered three of the women with PCOS and oligomenorrhoea, treatment with hCG on the basis of the randomized controlled trial of Quenby and Farquharson (1994) but have stopped this practice since the publication of the Royal College of Obstetricians and Gynaecologists' guidelines (2003) , without affecting pregnancy outcome, although the numbers are still too small for statistical judgement.
In conclusion, a one-stop RMC significantly reduced 'the interval' and increased the throughput in the clinic. Although we did not routinely offer all our patients investigations for endometrial abnormalities, the live birth rate was similar to that from other units, including those units where such screening is offered. This will confirm the observations that supportive therapy is probably the single most effective therapy for couples with recurrent miscarriages irrespective of the putative aetiological factor.
